{
  "id": 155118,
  "title": "Goldman-Backed Biotech Attovia Raises $289 Million in US IPO",
  "url": "https://urgent.news/2026/08/05/goldman-backed-biotech-attovia-raises-289-million-in-us-ipo",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-05T01:06:12.000Z",
  "source": {
    "name": "Bloomberg",
    "slug": "bloomberg",
    "url": "https://www.bloomberg.com/news/articles/2026-08-05/goldman-backed-biotech-attovia-raises-289-million-in-us-ipo"
  },
  "original_language": "en",
  "account": null,
  "summary": "Attovia Therapeutics Inc., an early-stage drug developer focused on immune system diseases with high unmet need, raised $289 million in a US initial public offering that priced at the top of its marketed range.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Financial Post",
        "title": "Goldman-Backed Biotech Attovia Raises $289 Million in US IPO",
        "url": "https://urgent.news/2026/08/05/goldman-backed-biotech-attovia-raises-289-million-in-us-ipo-156057",
        "published": "2026-08-05T01:47:07.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}